Phase II study of azacitidine with pembrolizumab in patients with intermediate‐1 or higher‐risk myelodysplastic syndrome
暂无分享，去创建一个
M. Andreeff | H. Kantarjian | G. Garcia-Manero | J. Cortes | Xuelin Huang | T. Kadia | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | N. Jain | G. Nogueras-Gonzalez | Y. Alvarado | K. Soltysiak | S. Pierce | G. Montalban-Bravo | P. Bose | K. Naqvi | Kunhwa Kim | X. Dong | K. Chien | Kimberly B. Sheppard | C. Klingner-Winton | X. Dong